) Sayama , K. , Shiraishi , S. , Shirakata , Y. , Kobayashi , Y. , Seya , T. and Miki , Y.Expression and characterization of membrane co\factor protein (MCP) in human skin . J. monoclonal antibody, D17, was not detected in 5 (71.4%) SCLC and in 4 (22.2%) non\small\cell lung cancer. This disparity was seen in most cell lines, irrespective of histological subtypes. The loss of D17 reactivity seemed to be pertinent to malignant phenotype, because most Bumetanide of the normal pulmonary cells possessed the D17 epitope. Furthermore, a cell line Bumetanide lacking DAF (IA10?/D17?) allowed alternative pathway\mediated homologous complement (C3) deposition after pretreatment with anti\MCP antibody. This raises Bumetanide a new possibility for immuno\targeting of cancer. These cell lines should be useful in studying the biology of lung cancer. strong class=”kwd-title” Keywords: Decay\accelerating factor (DAF, CD55), Flow cytometry, Lung cancer, Monoclonal antibody Abbreviations:SCLCsmall\cell lung cancerCR1complement receptor type one (C3b/C4b receptor, CD35)DAFdecay\accelerating factor (CD55)mAbmonoclonal antibodyMACmembrane attack complex that is formed by C5b\9MCPmembrane cofactor protein (CD46)NSCLCnon\small\cell lung cancer (adeno\, squamous, and large cell carcinomas)CD59an inhibitor of MAC formation REFERENCES 1. ) Parkin Bumetanide , Rabbit polyclonal to IL9 D. M , L??r? , E. and Muir , C. S.Estimation of the worldwide frequency of sixteen major cancers in 1980 . Int. J. Cancer , 41 , 184 C 197 ( 1988. ). [PubMed] [Google Scholar] 2. ) Stanley , K. and Stjernsward , J.Lung cancer a worldwide health problem . Chest , 96 , 1S C 5S ( 1989. ). [PubMed] [Google Scholar] 3. ) Seifter , E. J. and Ihde , D. C.Small cell lung cancer: a distinct clinicopathologic entity . In Lung Cancer. A Comprehensive Treatise , ed. Bitran J. D. , Golomb H. M. , Little A. G. and Weichselbaum R. R. , pp. 257 C 279 ( 1988. ). Grune & Stratton; , Orlando . [Google Scholar] 4. ) Fraser , R. G. , Par , J. A. P. , Par , P. D. , Fraser , R. S. and Genereux , G. P.Neoplastic disease of the lung . In Diagnosis of Diseases of the Chest , 3rd Ed. , pp. 1327 C 1699 ( 1989. ). W. B. Saunders; , Philadelphia . [Google Scholar] 5. ) Tateishi , R. , Horai , T. and Hattori , S.Demonstration of argyrophil granules in small cell carcinoma of the lung . Virchows Arch. A. Pathol. Anat. Histol. , 377 , 203 C 210 ( 1978. ). [PubMed] [Google Scholar] 6. ) Gazdar , A. F. and Carney , D. N.Endocrine properties of small cell carcinoma of the lung . In The Endocrine Lung in Health and Disease , ed. Becker K. L. and Gazdar A. F. , pp. 501 C 508 ( 1984. ). W. B. Saunders; , Philadelphia . [Google Scholar] 7. ) Carney , D. N. , Marangos , P. J. , Ihde , D. C. , Bunn , P. A. , Jr. , Cohen , M. H. , Minna , J. D. and Gazdar , A. F.Serum neuron\specific enolase: a marker for disease extent and response to therapy of small\cell lung cancer . Lancet , i , 583 C 585 ( 1982. ). [PubMed] [Google Scholar] 8. ) Cheung , N\K. V. , Walter , E. I. , Smith\Mensah , W. H. , Ratnoff , W. D. , Tykocinski , M. L. and Medof , M. E.Decay\accelerating factor protects human tumor cells from complement\mediated cytotoxicity in vitro . J. Clin. Invest. , 81 , 1122 C 1128 ( 1988. ). [PMC free article] [PubMed] [Google Scholar] 9. ) Fearon , D. T.Regulation of the amplification of C3 convertase of human Bumetanide complement by an inhibitory protein isolated from human erythrocyte membrane . Proc. Natl. Acad. Sci. USA , 76 , 5867 C 5871 ( 1979. ). [PMC free article] [PubMed] [Google Scholar] 10. ) Nicholson\Weller , A. , Burge , J. , Fearon , D. T. , Weller , P. F. and Austen , K. F.Isolation of a human erythrocyte membrane glycoprotein with.
Categories:Syk Kinase